The increased NADH/NAD+ ratio found in shCtBP2 cells compared to the scrambled control (Figure 3G) and untransfected MDA-MB231 cells (Figure 2E) confirms that cancer metabolic rewiring by NADH is involved in the downstream CtBP2 activation and is able to alter the epigenetic landscape. This evidence concerns the gene CTBP2 and cancer.